Welcome to our dedicated page for Carlisle SEC filings (Ticker: CSL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Carlisle Companies Incorporated (NYSE: CSL) SEC filings page on Stock Titan provides access to the company’s official U.S. Securities and Exchange Commission disclosures, offering a detailed view of its building products business and financial position. Carlisle’s common stock is registered under Section 12(b) of the Exchange Act and trades on the New York Stock Exchange under the symbol CSL.
Carlisle regularly files Form 8-K current reports to disclose material events. Recent 8-Ks include items on quarterly financial results, leadership appointments, share repurchase authorizations, and capital markets transactions such as public offerings of senior notes. These filings outline segment performance for Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT), as well as information on new debt, underwriting agreements, and other material definitive agreements.
Investors can also use this page to locate Carlisle’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide more extensive detail on its building envelope products and solutions, risk factors, segment information, and accounting policies. In addition, the SEC database linked through this page includes other filings that may cover topics like share repurchase programs, dividend declarations, and governance matters.
Stock Titan enhances these regulatory documents with AI-powered summaries that explain key points from lengthy filings, helping users quickly understand the significance of results announcements, new debt offerings, or board-approved programs. Real-time updates from EDGAR mean that new CSL filings, including Forms 8-K, 10-K, 10-Q, and any insider transaction reports on Form 4, become accessible as they are posted, giving investors a structured way to review Carlisle’s regulatory history and ongoing disclosure practices.
Carlisle Companies reported 2025 revenues of $5,019.9 million, slightly above 2024, with operating income of $1,002.5 million and diluted earnings per share from continuing operations of $17.16, down from $18.34 as margins softened.
Carlisle Construction Materials grew revenue to $3,721.7 million, supported by commercial re‑roofing and the MTL acquisition, but its operating margin fell to 26.8% on higher costs and R&D. Carlisle Weatherproofing Technologies revenue was stable at $1,298.2 million, while its operating margin declined to 7.8% due to lower volumes and higher unit costs.
The company generated $1,101.8 million in operating cash flow and ended the year with $1,112.1 million in cash. It repurchased $1.3 billion of stock, paid $181.1 million in dividends, and issued new 5.25% 2035 and 5.55% 2040 notes, increasing long‑term debt to $2,881.6 million while emphasizing its Vision 2030 strategy focused on energy‑efficient building products, innovation and disciplined capital deployment.
Carlisle Companies executive Stephen Schwar, Vice Chair of CCM, reported several stock transactions. On February 12, 2026, he exercised an employee stock option for 1,500 shares of common stock at an exercise price of $108.72 per share, increasing his direct holdings to 14,589 shares.
That same day, Schwar executed two open-market sales of Carlisle common stock. He sold 1,500 shares at a price of $417.16 per share, then sold an additional 4,549 shares at $417.42 per share. After these sales, he directly owned 8,540 Carlisle common shares.
Carlisle Companies has a holder planning to sell 6,049 shares of common stock under Rule 144 through UBS Financial Services on the NYSE, with an aggregate market value of 2,419,600. Shares outstanding were 41,785,774 common shares at the time referenced.
The shares come from prior equity awards, including stock options exercised on 02/12/2016 and various restricted stock awards and performance stock units granted between 08/24/2020 and 02/08/2025.
Carlisle Companies VP & Chief Financial Officer Kevin P. Zdimal reported multiple share transactions in company common stock. On February 10, 2026, he exercised 7,720 employee stock options at an exercise price of $222.35 per share, converting them into common stock.
That same day, he sold a total of 24,180 common shares in a series of market transactions at weighted average prices ranging from about $405.19 to $417.61, each executed in multiple trades within stated price ranges. After these transactions, he beneficially owned 30,094 common shares, all held directly.
Carlisle Companies (CSL) Chair, President & CEO D. Christian Koch reported an option exercise and stock sales. On February 10, 2026, he exercised an employee stock option for 36,260 shares of common stock at an exercise price of $222.35 per share.
On the same date, he sold common stock in several transactions: 12,280 shares at $412.31, 10,622 shares at $413.49, 11,652 shares at $414.18 and 1,706 shares at $415.03, with each sale executed in multiple trades within stated price ranges. After these transactions, he directly owned 113,238 shares and indirectly held 135,000 shares through a limited liability company for which he has full investment authority.
Carlisle Companies VP of Sustainability David W. Smith reported option exercises and share sales in the company’s stock. On February 10, 2026, he exercised employee stock options for 1,020 shares at $222.35 and 780 shares at $250.86, converting them into common stock.
On the same day, he sold 1,020 shares and 780 shares of common stock at $414.05 per share. After these transactions, he directly beneficially owned 3,697 shares of Carlisle Companies common stock.
A holder of common stock of the issuer associated with symbol CSL has filed a notice of proposed sale under Rule 144. The filing covers 1,800 shares to be sold through UBS Financial Services Inc. with an aggregate market value of $720,000, based on an outstanding share count of 42,500,000 shares.
The shares are planned to be sold on or about February 10, 2026 on the NYSE. According to the notice, the securities were acquired on February 10, 2026 via an option exercise from the issuer, paid in cash. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.
Carlisle Companies has a planned stock sale disclosed in a Form 144 notice. A shareholder intends to sell up to 36,260 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of $14,504,000. The shares were acquired by exercising stock options for cash on 02/10/2026. Shares outstanding were 42,500,000, providing context for the planned sale size.
CSL insider Kevin Zdimal has filed a notice to sell 4,862 shares of Common Stock. The planned sale, through UBS Financial Services Inc., has an aggregate market value of $1,944,800 based on the filing and is listed for execution on 02/10/2026 on the NYSE.
The filing notes that 41,700,000 shares of Common Stock were outstanding. The shares to be sold were acquired on 01/31/2026 from the issuer via restricted stock awards (994 shares) and performance stock units (3,868 shares. In the past three months, Zdimal also sold 19,318 Common Stock shares for gross proceeds of $7,841,012.
CSL filed a Rule 144 notice for the proposed sale of 19,318 shares of common stock through UBS Financial Services on NASDAQ.
The filing lists an aggregate market value of 7,727,200 for these shares and notes 41,700,000 shares of common stock outstanding. The shares to be sold come from option exercises, restricted stock awards, and performance stock units acquired between 02/02/2024 and 02/10/2026.